improved diagnostic accuracy. However, the number of patients who die due to this disease also increases . TC is a heterogeneous disease that is classified into differentiated thyroid carcinoma (DTC) (95 %), undifferentiated (anaplastic) thyroid carcinoma (ATC) and medullary thyroid carcinoma (MTC). DTCs derive from the follicular epithelial cells, and
carcinoma (FTC) termed as differentiated thyroid cancer (DTC) contribute to majority of thyroid cancers sharing a superior prognosis. Medullary thyroid carcinoma (MTC), mostly acquired as a part of familial syndromes, display only modest cure rates. While surgical resection followed by radioiodine therapy remains the treatment of choice for localized thyroid cancer, it fails to eradicate tumors with aggressive behavior. In marked contrast to DTC, anaplastic carcinoma (ATC), an undifferentiated sub-type
INTRODUCTION 4 ORIGIN AND EVOLUTION 5 ENVIRONMENT ANALYSIS (PEST) 7 STRUCTURAL INDUSTRY ANALYSIS (PORTER) 8 STRATEGIC ISSUES FACING THE INDUSTRY 11 STRATEGIC GROUPS IN THE INDUSTRY ACCORDING TO MARKET/DRUG/FUNCTIONING 15 PROCESS FLOW: IMPORTANT FUNCTIONS 16 STRATEGIC RESPONSES TO CHALLENGES: SIMPLE CORRELATION BETWEEN GROUP AND PERFORMANCE 19 REGULATOR’S ROLE 21 POSSIBLE FUTURE DIRECTION 21 CONCLUSION 22 REFERENCE 22 Executive summary This report provides an analytical strategic review
Coordination between the Military and Civilian Organisations: Issues and Solutions The work described in this document has been undertaken by the Human Factors Integration Defence Technology Centre, part funded by the Human Capability Domain of the U.K. Ministry of Defence Scientific Research Programme. © BAE Systems 2009 The authors of this report have asserted their moral rights under the Copyright, Designs and Patents act, 1988, to be identified as the authors of this work. Reference ..
GlaxoSmithKline company profile Francis Weyzig Amsterdam, October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers, develops, manufactures and markets branded human health products. Headquarters: UK, with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA, France, Germany, UK, Italy and Japan Employees: approximately 103,000 GSK key figures
ECS8C_C01.qxd 22/10/2007 11:54 Page 597 CASE STUDIES ECS8C_C01.qxd 22/10/2007 11:54 Page 598 ECS8C_C01.qxd 22/10/2007 11:54 Page 599 Guide to using the case studies The main text of this book includes 87 short illustrations and 15 case examples which have been chosen to enlarge speciﬁc issues in the text and/or provide practical examples of how business and public sector organisations are managing strategic issues. The case studies which follow allow the